Erlotinib Completed Phase N/A Trials for Malignant Neoplasm of Pancreas

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01782690An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer